Large clinical study starting in India The planned

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 9, 2015 at 6:30 AM

Large clinical study starting in India

The planned multi-center clinical study in India has been initiated and the first patients recruited at two reputable hospitals. The purpose of the study is to further validate the efficiency and patient safety of Bactiguard’s Foley catheters in the prevention of catheter-related urinary tract infections. Healthcare associated infections are a huge problem worldwide. In India, with the largest consumption of antibiotics in the world and a high level of multi -resistant bacteria, healthcare associated infections lead to an even greater challenge. - We have great challenges in healthcare associated infections. It is a growing problem that we seriously need to act against and overcome. We look forward to implementing the Bactiguard Infection Prevention solution, and to bring down the number of infections significantly, says Dr. Pankaj R. Shah, Professor & Head, Department of Nephrology Institute of Kidney Diseases & Research Centre and Institute of Transplantation Sciences Civil Hospital, Ahmedabad. The clinical study includes 1 000 patients in total and will be conducted at six different sites in India, to reflect differences in the population between the regions. The study was initiated in December 2015 and the results are expected by the end of 2016. The target groups include patients affected by stroke, dementia, neuromuscular disease, bladder obstruction, urological surgery or other elective surgery, where the catheter is expected to be in use for more than two days. - The study is an important element in implementing our products at some of the major hospitals in India. The results and experience from the study will further strengthen our clinical evidence and will also be a powerful marketing tool in India, says Cecilia Edström, Director of Sales and New Business. Bactiguard has already received product approval in India. The aim of this post -approval study is to further validate the safety and infection prevention properties of Bactiguard’s technology in the Indian population. The study has started at two sites in Ahmedabad, one private and one public. Apollo hospital has a capacity of 350 patients and there, the Bactiguard catheters will be used throughout the hospital. At Civil Hospital, one of Asia’s largest public hospitals with a capacity of some 4 000 patients, a specific unit named the Institute of Kidney Diseases and Research Center will be responsible for the study. This Institute was founded by Dr H L Trivedi in 1981 and conducts between 10 and 12 transplantations every day. Some of the doctors at the Institute have been trained at the Karolinska University Hospital. In addition to these two sites, trials will be initiated at PGI Chandigarh in the North of India before the end of the year. At the beginning of next year, three more sites will be added in the South and East of India. - The Bactiguard Infection Protection solution has proven its superiority. This is the first such clinical study in the Indian population and we are excited to lead the future of infection control measures within the medical device industry of India, says Dr Bhaumik Mody, CEO of EthiTrials CRO (Contract Research Organization, Bactiguard’s partner for clinical studies in India). For further information, please contact: Ulrika Berglund, Head of External Affairs, mobile: 46 708 800 407 About Bactiguard Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, Latin America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Betterness Expands Health Networks with $3.5M Boost

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

HiTHIUM Joins Cambridge to Boost Global Energy Storage

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Black Bayou Kicks Off Major Gas Storage Build in Louisiana

Breaking Ground on a Massive Energy Undertaking Well, folks, Black Bayou's finally breaking ground on their colossal gas storage project in Cameron Parish, Louisiana. They're not just playing around—this thing's set to be a juggernaut, with an imposing 44.4 Bcf of working gas capacity nestled right on top of the Black Bayou salt dome. Talk about marking territory, huh?...

LEOTEK's AI Tech Shaping Smarter Cities at COP31

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

Dyania, NVIDIA Team Up: AI Transforming Patient Care

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

LaserAway Expands to 244 Clinics Over 20 Years

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

JardogsHealth Taps Industry Titans for Growth Council

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Data Center Transformers on the Brink of a Boom

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Emergency Strobe Light Device Eyes Market Potential

An Idea Sparked in San Marcos This ain't your typical cocktail party chat. We're diving into a story born from necessity—where someone's trying to shave seconds off a life-or-death situation. From the busy streets of San Marcos, California, an inventor has brought a practical gem to the table: the LIFE STROBE. This gizmo is not just a bulb with a new flash pattern. It's...